medline.ch Onkologie Respirationstrakt

	Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer. N Engl J Med Wu YL, Tsuboi M, He J, John T, Grohe C, Majem M, Goldman JW, Laktionov K, Kim SW, Kato T, Vu HV, Lu S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Zeng L, Hodge R, Atasoy A, Rukazenkov Y, Herbst RS, ADAURA Investigators.. PMID: 32955177 [PubMed - as supplied by publisher]
	Necitumumab plus platinum-based chemotherapy versus chemotherapy alone as first-line treatment for stage IV non-small cell lung cancer: a meta-analysis based on randomized controlled trials. Ann Palliat Med Wang L, Liao C, Li M, Zhang S, Yi F, Wei Y, Yu J, Zhang W. PMID: 32954751 [PubMed - as supplied by publisher]
	Osimertinib for EGFR-mutant lung cancer with central nervous system metastases: a meta-analysis and systematic review. Ann Palliat Med Wang N, Zhang Y, Mi Y, Deng H, Chen G, Tang Z, Mao J, Cui S, Zhang Y, Wang L. PMID: 32954743 [PubMed - as supplied by publisher]
	Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY. Cancer Sci Nishio M, Seto T, Reck M, Garon EB, Chiu CH, Yoh K, Imamura F, Park K, Shih JY, Visseren-Grul C, Frimodt-Moller B, Zimmermann A, Homma G, Enatsu S, Nakagawa K, RELAY Study Investigators.. PMID: 32954593 [PubMed - as supplied by publisher]
	Earlier multidisciplinary palliative care intervention for people with lung cancer: a systematic review and meta-analysis. Transl Lung Cancer Res Kochovska S, Ferreira DH, Luckett T, Phillips JL, Currow DC. PMID: 32953543 [PubMed]
	Multidisciplinary team care in advanced lung cancer. Transl Lung Cancer Res Kowalczyk A, Jassem J. PMID: 32953542 [PubMed]
	Locally advanced non-small cell lung cancer: the place of specialist thoracic surgery in the multidisciplinary team. Transl Lung Cancer Res Al Zaidi M, Wright GM. PMID: 32953541 [PubMed]
	Implementation of lung cancer multidisciplinary teams: a review of evidence-practice gaps. Transl Lung Cancer Res Rankin NM, Fradgley EA, Barnes DJ. PMID: 32953540 [PubMed]
	Accuracy of lung cancer staging in the multidisciplinary team setting. Transl Lung Cancer Res Liam CK, Liam YS, Poh ME, Wong CK. PMID: 32953539 [PubMed]
	A review on the impact of lung cancer multidisciplinary care on patient outcomes. Transl Lung Cancer Res Heinke MY, Vinod SK. PMID: 32953538 [PubMed]
	Optimizing lung cancer MDT data for maximum clinical impact-a scoping literature review. Transl Lung Cancer Res Stone E, Rankin N, Currow D, Fong KM, Phillips JL, Shaw T. PMID: 32953537 [PubMed]
	Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms. Transl Lung Cancer Res Xu N, Wang L, Li C, Ding C, Li C, Fan W, Cheng C, Gu B. PMID: 32953527 [PubMed]
	Challenges and issues surrounding the use for translational research of human samples obtained during the COVID-19 pandemic from lung cancer patients. Transl Lung Cancer Res Hofman P. PMID: 32953526 [PubMed]
	COVID-19 and early-stage lung cancer both featuring ground-glass opacities: a propensity score-matched study. Transl Lung Cancer Res Zhang YJ, Yang WJ, Liu D, Cao YQ, Zheng YY, Han YC, Jin RS, Han Y, Wang XY, Pan AS, Dai JY, Sun QF, Zhao FQ, Yang QY, Zhang JH, Liu SJ, Da Q, Guo W, Li CQ, Zhang WT, Wu H, Chen XS, Ji AQ, Xiang J, Chen K, Feng XJ, Zhang XF, Cao QQ, Qin L, Li J, Zhou M, Lu Y, Wang CF, Yan FH, Li HC, Qu JM. PMID: 32953523 [PubMed]
	A multicenter real-world study of tumor-derived DNA from pleural effusion supernatant in genomic profiling of advanced lung cancer. Transl Lung Cancer Res Jin S, Zhou C, Hou X, Fan Z, Zhao J, Ai X, Chu Y, Chen R, Guo R, Chen L. PMID: 32953522 [PubMed]
	Development of a multivariable prediction model to estimate the remaining lifespan of elderly patients with cerebral metastases from small-cell lung cancer. Transl Lung Cancer Res Rades D, Nguyen T, Janssen S, Schild SE. PMID: 32953515 [PubMed]
	PD-L1 as a prognostic biomarker in surgically resectable non-small cell lung cancer: a meta-analysis. Transl Lung Cancer Res Tuminello S, Sikavi D, Veluswamy R, Gamarra C, Lieberman-Cribbin W, Flores R, Taioli E. PMID: 32953509 [PubMed]
	Hazard ratio of progression-free survival is an excellent predictor of overall survival in phase III randomized controlled trials evaluating the first-line chemotherapy for extensive-disease small-cell lung cancer. Transl Lung Cancer Res Chen H, Horita N, Ito K, Hara Y, Kobayashi N, Kaneko T. PMID: 32953508 [PubMed]
	Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis. Transl Lung Cancer Res Liang J, Li M, Sui Q, Hu Z, Bian Y, Huang Y, Zhan C, Jiang W, Wang Q, Tan L. PMID: 32953506 [PubMed]
	Prognostic value of log odds of positive lymph nodes in node-positive lung squamous cell carcinoma patients after surgery: a SEER population-based study. Transl Lung Cancer Res Yu Y, Zhang P, Yao R, Wang J, Wang P, Xue X, Xiao J, Wang Z. PMID: 32953505 [PubMed]

Artikel 1 - 20 / 110036

Seite 1 von 5502

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung